Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies
Sign Up to like & getrecommendations! Published in 2021 at "Molecules"
DOI: 10.3390/molecules26123532
Abstract: Triple-negative breast cancer (TNBC) is a heterogeneous subtype of tumors that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. The mainstay of treatment remains chemotherapy, but the therapeutic outcome remains inadequate. This… read more here.
Keywords: breast; selective targeting; breast cancer; tafuramycin ... See more keywords